Prevention of post-ERCP pancreatitis

doi:10.4291/wjgp.v5.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8603)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

542

WORD

388

HTML

4450

Tables (1-3)

268

Sum=5648

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1516

Download

1439

Sum=2955

Feb 15, 2014 (publication date) through Jan 17, 2025

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Pathophysiol. Feb 15, 2014; 5(1): 1-10
Published online Feb 15, 2014. doi: 10.4291/wjgp.v5.i1.1

Table 3 Pharmacological agents studied according to postulated mechanism of action

Postulated mechanismof action	Agents
Interruption of inflam matory cascade	NSAIDs, steroids, interleukin-10, allopurinol, adrenaline spray, pentoxifylline, platelet-activating factor-acetylhidrolase, semapimod, aprepitant, risperidone
Reduction of pancreatic enzyme secretion	Octreotide, somatostatin, calcitonin
Inhibition of protease activity	Gabexate mesilate, heparin, ulinastatin, nafamostat, magnesium sulphate
Reduction of Sphincter- of-Oddi pressure	Nitroglycerin, nifedipine, botulinum toxin, lidocaine, secretin, phosphodiesterase inhibitor type 5
Prevention of infection	Antibiotics
Anti-oxidants	Beta-carotene, N-acetylcysteine, sodium selenite
Anti-metabolites	5-fluorouracil

NSAIDs: Non-steroidal anti-inflammatory drugs.

Citation: Wong LL, Tsai HH. Prevention of post-ERCP pancreatitis. World J Gastrointest Pathophysiol 2014; 5(1): 1-10
URL: https://www.wjgnet.com/2150-5330/full/v5/i1/1.htm
DOI: https://dx.doi.org/10.4291/wjgp.v5.i1.1